Wednesday, February 10, 2010, 11:06pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Kendle International Inc. (KNDL)

At 10:49PM SGT: 19.26 USD  Down 0.20 (1.03%)  
 MORE ON KNDL 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 Kendle International Inc. (NasdaqNM:KNDL) Delayed quote dataEdit
Last Trade:19.26 USD
Trade Time:10:49PM SGT
Change:Down 0.20 (1.03%)
Prev Close:19.46
Open:19.42
Bid:19.24 x 100
Ask:19.28 x 100
1y Target Est:13.50
Day's Range:19.25 - 19.42
52wk Range:8.28 - 23.54
Volume:1,370
Avg Vol (3m):168,775
Market Cap:286.61M
P/E (ttm):12.82
EPS (ttm):1.50
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add KNDL to Portfolio   Download Data

 HEADLINES 
•5-Star Stocks on the Upswing
at Motley Fool (Fri, Jan 22)
•Contract Researchers, PBMs Eye Strong 2010
Investor's Business Daily (Fri, Jan 1)
•We Expect Ailing CROs to Recover
Morningstar.com (Wed, Nov 25)
•KENDLE INTERNATIONAL INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financi
EDGAR Online (Tue, Nov 17)
•KENDLE INTERNATIONAL INC Financials
EDGAR Online Financials (Fri, Nov 13)
•KENDLE INTERNATIONAL INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Tue, Nov 10)
•KENDLE INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
EDGAR Online (Thu, Nov 5)
•KENDLE INTERNATIONAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification to Rig
EDGAR Online (Thu, Aug 20)
•KENDLE INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
EDGAR Online (Thu, Aug 6)
•KENDLE INTERNATIONAL INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhi
EDGAR Online (Wed, Jul 29)
More Headlines for KNDL...
 ANALYST 
EPS Est (next year) (Dec-09) :1.89
EPS Est (in 2 years) (Dec-10) :1.49
Avg Rec (current)*:3.3
PEG Ratio:0.76
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Kendle International Inc., a clinical research organization, provides clinical development services on a contract basis to the biopharmaceutical industry worldwide.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices